News Real-world diabetes study CONFIRMs positive comparative effi... Novo Nordisk presented the latest results for its diabetes injectable Tresiba last weekend.
News Bayer trial combines two top drugs for kidney disease Data from the CONFIDENCE trial shows the value of combining Bayer's Kerendia with an SGLT2 inhibitor to treat chronic kidney disease in diabetics.
